Listed on GrantGunner. Last checked 3 Oct 2026.
About this grant
This is a project that supports domestic biotech companies and SMEs in product commercialization, including process development for vaccines and biopharmaceuticals as well as the production of (non-)clinical trial samples. It provides support for manufacturing process optimization, scale-up, cell bank manufacturing, clinical trial sample production, and quality and stability testing, offering up to 350 million won in government funding per company.
Who can apply
Domestic pharmaceutical and bio companies possess technological capabilities but lack a manufacturing base.